Results 11 to 20 of about 464,946 (417)

Oestrogen as a calcium channel blocker [PDF]

European Heart Journal, 1996
This paper reviews the evidence for calcium-antagonist properties of oestrogen which may offer long-term protective effects on the cardiovascular system in postmenopausal women. Oestrogen has already been shown to have a beneficial effect on cholesterol metabolism and deposition, thereby inhibiting the formation of atherosclerotic plaque and coronary ...
Peter Collins, Carolyn M. Beale, Giuseppe Rosano   +2 more
openalex   +4 more sources

Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action [PDF]

Advanced Pharmaceutical Bulletin, 2011
Introduction: DHPEE is a newly synthesized compound by merging the key structural elements in an angiotensin receptor blocker (Telmisartan) with key structural elements in 1,4- dihydropyridine calcium channel blocker (Nifedipine).
Hossein Babaei, Farzaneh Ebrahimi, Javid Shahbazi Mojarrad, Yadollah Azarmi, Afsaneh Gharehbagheri   +4 more
doaj   +2 more sources

Successful treatment of severe calcium channel blocker poisoning, new experience with the guidance of invasive hemodynamic monitoring in a 17-year-old girl: a case report. [PDF]

J Med Case Rep
Background Calcium channel blocker poisoning is one of the most lethal cardiac drugs overdoses. Calcium and high-dose insulin infusion are the first-line therapy for symptomatic patients, and Intralipid emulsion infusion is useful for refractory cases ...
Saeed A, Naghshzan A.
europepmc   +2 more sources

Intravenous calcium therapy in calcium channel blocker poisoning - A double-edged sword. [PDF]

J Anaesthesiol Clin Pharmacol
Rajaram B, Ravikumar RH, Sharma S, Khanna P.   +3 more
europepmc   +2 more sources

Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study

Critical Care Explorations, 2021
OBJECTIVES:. The aim was to evaluate the effect of dihydropyridine calcium channel blocker on the prognosis for moderate-severe pulmonary acute respiratory distress syndrome in hypertension patients. DESIGN:.
Fengyuan Li, MD, Chang Gao, MD, Jiahao Chen, MD, Ling Yang, MD, Shiqi Guo, MD, Dongmei Jin, MD, Xiaoting Lu, MD, Yin Sheng, MD, Xiaoxia Ji, MD, Qiang Guo, MD   +9 more
doaj   +1 more source

Development of severe junctional bradycardia after dexmedetomidine infusion in a polypharmacy patient: a case report and literature review [PDF]

Kosin Medical Journal, 2023
The authors report a case of newly manifested severe junctional bradycardia following dexmedetomidine administration during spinal anesthesia in a polypharmacy patient.
Soeun Jeon, Eunsoo Kim, Sun Hack Lee, Sung In Paek, Hyun-Su Ri, Dowon Lee   +5 more
doaj   +1 more source

Calcium Channel Blockers [PDF]

The Journal of Clinical Hypertension, 2011
KEY POINTS AND PRACTICAL RECOMMENDATIONS: •  Calcium channel blockers, which dilate arteries by reducing calcium flux into cells, effectively lower blood pressure, especially in combination with other drugs, and some formulations of agents of this class are approved for treating angina or cardiac dysrhythmias.
William J. Elliott, C. Venkata S. Ram
openaire   +3 more sources

Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension

medRxiv, 2020
The coronavirus disease (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread to >200 countries posing a global public health concern. Patients with comorbidity, such as hypertension suffer more severe
Lei-ke Zhang, Yuanyuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei Shang, Yan Wu, Shufen Li, Yulan Zhang, Zhao-Nian Hao, Hongbo Chen, R. Jin, Wei Liu, Hao Li, Kefang Peng, Gengfu Xiao   +15 more
semanticscholar   +1 more source

PROFIL PENGGUNAAN OBAT HIPERTENSI PADA PASIEN HIPERTENSI DENGAN KEBIASAAN MEROKOK DI RSUD LANDAK KALIMANTAN BARAT [PDF]

, 2023
Hipertensi merupakan salah satu penyebab kematian dini pada masyarkat di dunia. Data Kemenkes RI 2019 Kalimantan Barat menempati urutan kelima penderita hipertensi sebanyak 36,99%.
Angi, Maria Agnesi
core   +2 more sources

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS

Рациональная фармакотерапия в кардиологии, 2015
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented.
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta   +3 more
doaj   +3 more sources